WallStreetZenWallStreetZen

NASDAQ: CNTB
Connect Biopharma Holdings Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CNTB

Based on 1 analyst offering 12 month price targets for Connect Biopharma Holdings Ltd.
Min Forecast
$8.00+483.94%
Avg Forecast
$8.00+483.94%
Max Forecast
$8.00+483.94%

Should I buy or sell CNTB stock?

Based on 1 analyst offering ratings for Connect Biopharma Holdings Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNTB stock forecasts and price targets.

CNTB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-17

1 of 1

Forecast return on equity

Is CNTB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is CNTB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CNTB revenue forecast

What is CNTB's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$103.9M
Avg 2 year Forecast
$35.5M
Avg 3 year Forecast
$28.6M

CNTB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNTB$1.37$8.00+483.94%Buy
YS$0.81$5.25+548.15%Buy
TPST$3.44$25.00+626.74%Strong Buy
SPRO$1.42$7.00+392.96%Buy
AFMD$4.88$13.33+173.22%Buy
View Top Biotech Stocks

Connect Biopharma Holdings Stock Forecast FAQ

Is Connect Biopharma Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CNTB) stock is to Buy CNTB stock.

Out of 1 analyst, 0 (0%) are recommending CNTB as a Strong Buy, 1 (100%) are recommending CNTB as a Buy, 0 (0%) are recommending CNTB as a Hold, 0 (0%) are recommending CNTB as a Sell, and 0 (0%) are recommending CNTB as a Strong Sell.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.

What is CNTB's revenue growth forecast for 2024-2026?

(NASDAQ: CNTB) Connect Biopharma Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Connect Biopharma Holdings's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast CNTB's revenue for 2024 to be $5,723,819,347, with the lowest CNTB revenue forecast at $2,752,392,552, and the highest CNTB revenue forecast at $8,695,246,141. On average, 2 Wall Street analysts forecast CNTB's revenue for 2025 to be $1,954,777,293, with the lowest CNTB revenue forecast at $1,165,427,477, and the highest CNTB revenue forecast at $2,744,127,109.

In 2026, CNTB is forecast to generate $1,575,944,484 in revenue, with the lowest revenue forecast at $297,555,952 and the highest revenue forecast at $2,854,333,017.

What is CNTB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CNTB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CNTB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CNTB price target, the average CNTB price target is $8.00, with the highest CNTB stock price forecast at $8.00 and the lowest CNTB stock price forecast at $8.00.

The Wall Street analyst predicted that Connect Biopharma Holdings's share price could reach $8.00 by Apr 17, 2025. The average Connect Biopharma Holdings stock price prediction forecasts a potential upside of 483.94% from the current CNTB share price of $1.37.

What is CNTB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CNTB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.